Metabolic Reprogramming: A Byproduct or a Driver of Cardiomyocyte Proliferation?
Xiaokang Chen(Army Medical University), Wei Eric Wang(Army Medical University), Hao Wu(Army Medical University), Lingyan Liu(SKiN Health), Steven R. Houser(Temple University), Ya Liu(Army Medical University)
Cited by 62
Related Papers
Research Priorities in Hypertrophic Cardiomyopathy
|Circulation|2010|118
Irisin exerts a therapeutic effect against myocardial infarction via promoting angiogenesis
|Acta Pharmacologica Sinica|2019|83
YAP activity protects against endotoxemic acute lung injury by activating multiple mechanisms
|International Journal of Molecular Medicine|2020|27